It’s official! The second 2023 MOGAD global research grant category, the Accelerator Grant, has been awarded, accepted and received! Part of The MOG Project’s Research for Rare program, this grant provides for architecture, infrastructure, and technology funding to be used in support of any future MOGAD research projects.
Congratulations
to our first Accelerator Grant recipient::
- Dr. Maria Houtchens, MD, MSc and Dr. Tanuja Chitnis, MD, FAAN – Brigham and Women’s Hospital, Harvard
University for the “Development of a Prospective MOGAD Pregnancy Registry: PREG-MOGAD.”
Special thanks to our SRO and Scientific Advisory Board Member, Dr. Lisa K. Ryan, Ph.D, and The MOG Project President, Amy Ednie, for leading this award cycle.
The MOG Project is a 501(c)3 nonprofit organization dedicated to funding researchers as part of our mission for the advancement of understanding, predicting, treating, and eventually curing Myelin Oligodendrocyte Glycoprotein Antibody Disease, or MOGAD, a neuroinflammatory condition that attacks the optic nerve, brain, and/or spinal column. For more information visit The MOG Project.
